Cannabidiol for Anxiety in Women with Advanced Breast Cancer
Author Information
Author(s): Nayak Manan M., Chai Peter, Catalano Paul J., Pirl William F., Tulsky James A., Tung Stephanie C., Lin Nancy U., Andrade Nicole, Johns Sabrina, Vaz Clint, Hughes Melissa, Braun Ilana M.
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
Does cannabidiol (CBD) improve cancer-related anxiety?
Conclusion
The study found that while CBD did not significantly reduce anxiety compared to placebo, it was safe and resulted in lower anxiety levels after ingestion.
Supporting Evidence
- Participants receiving CBD reported significantly lower anxiety levels 2 to 4 hours after ingestion compared to those receiving placebo.
- No grade 3 or 4 toxic effects were reported in the study.
- The primary end point comparing anxiety change scores was not statistically significant.
- Oral CBD was well tolerated by participants with advanced breast cancer.
Takeaway
This study looked at whether a single dose of CBD can help women with breast cancer feel less anxious before scans, and it found that CBD might help a little.
Methodology
This was a phase II, double-masked, placebo-controlled randomized clinical trial conducted at the Dana-Farber Cancer Institute.
Potential Biases
Potential confounding factors include the exclusion of participants taking antidepressants and the small sample size.
Limitations
The study excluded men and used a scale not validated in cancer patients, and it only tested a single dose of CBD.
Participant Demographics
Participants were women aged 18 and older with advanced breast cancer and clinical anxiety, predominantly White and non-Hispanic.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website